Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.
3 regions · 12 outlets · 14 reports — every source grouped by where each outlet is based. Region reflects only headquarters, not the subject of the report.
US
7 articles · 5 outlets
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soar
Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Moderna stock surges as melanoma vaccine trial shows "landmark moment
Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Other
6 articles · 6 outlets
Personalized mRNA cancer vaccine shows promise in extending life span in melanoma trial
Moderna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and…
MRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Promising Results for mRNA Cancer Vaccine from Moderna and Merck
STAT+: Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Merck and Moderna say cancer vaccine shows promise in preventing recurrence of melanoma
Middle East
1 article · 1 outlet